ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms and Therapies for Melanoma

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 20 May 2025 | Viewed by 496

Special Issue Editor


E-Mail Website
Guest Editor
Department of Histology, Medical University of Gdansk, 1a Debinki, 80-211 Gdansk, Poland
Interests: melanoma; patient-derived melanoma models; adjuvant therapy in melanoma; microenvironment in melanoma; skin cancer; skin; UV; vitamin D and its derivatives; dermatoendocrinology; mitochondria; oxidative stress

Special Issue Information

Dear Colleagues,

Melanoma, representing only a minor percentage of all skin neoplasms, is responsible for the vast majority of deaths caused by cutaneous cancers. Moreover, the incidence of this aggressive malignancy has been dynamically increasing worldwide since 1975. Before 2011, advanced melanoma patients could expect a 5-year survival rate of 10%. Novel advanced therapies and their combinations, including immunotherapy with the immune checkpoint inhibitors CTLA-4 or PD-1, as well as targeted therapy with BRAF and MEK inhibitors, have become a critical breakthrough in the clinical landscape of melanoma treatment, as they resulted in an increase in the 5-year overall survival rate for metastatic melanoma to as much as 36%. Unfortunately, a substantial proportion of patients still either fail to respond to the therapy or will relapse over time, implying that melanoma remains a demanding clinical problem. Taking this into account, it seems necessary to continuously search for novel molecular targets and therapeutic solutions to overcome this fatal cancer. Advances in the field of molecular oncology and an increasingly precise understanding of the mechanisms and interactions within cancer nests have drawn attention to the critical role of the tumor microenvironment at all stages of tumorigenesis, establishing a new promising direction in cancer research, including melanoma.

This Special Issue provides insights into the molecular mechanisms of melanoma development, including the role of the  tumor microenvironment, as well as recent advances in melanoma therapy, with a focus on novel potential therapeutic targets.

Dr. Anna Piotrowska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • melanoma
  • targeted therapy
  • BRAF/MEK inhibitors
  • immunotherapy
  • anti-PD-1 and anti-CTLA-4 immunotherapy
  • melanoma microenvironment
  • cancer-associated fibroblasts (CAFs)/melanoma-associated fibroblasts (MAFs)
  • MAPK (mitogen-activated protein kinase) signaling pathway

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

28 pages, 4414 KiB  
Review
Unravelling the Regulatory Roles of lncRNAs in Melanoma: From Mechanistic Insights to Target Selection
by Beatrice Moras and Claudia Sissi
Int. J. Mol. Sci. 2025, 26(5), 2126; https://doi.org/10.3390/ijms26052126 - 27 Feb 2025
Viewed by 387
Abstract
Melanoma is the deadliest form of skin cancer, and its treatment poses significant challenges due to its aggressive nature and resistance to conventional therapies. Long non-coding RNAs (lncRNAs) represent a new frontier in the search for suitable targets to control melanoma progression and [...] Read more.
Melanoma is the deadliest form of skin cancer, and its treatment poses significant challenges due to its aggressive nature and resistance to conventional therapies. Long non-coding RNAs (lncRNAs) represent a new frontier in the search for suitable targets to control melanoma progression and invasiveness. Indeed, lncRNAs exploit a wide range of regulatory functions along chromatin remodeling, gene transcription, post-transcription, transduction, and post-transduction to ultimately tune multiple cellular processes. The understanding of this intricate and flexible regulatory network orchestrated by lncRNAs in pathological conditions can strategically support the rational identification of promising targets, ultimately speeding up the setup of new therapeutics to integrate the currently available approaches. Here, the most recent findings on lncRNAs involved in melanoma will be analyzed. In particular, the functional links between their mechanisms of action and some frequently underestimated features, like their different subcellular localizations, will be highlighted. Full article
(This article belongs to the Special Issue Molecular Mechanisms and Therapies for Melanoma)
Show Figures

Figure 1

Back to TopTop